Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ram Yogev

Showing results (121-130 of 130) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 130 results.
The Journal of Infectious Diseases|March 7, 2018
Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and ChildrenUrsula J Buchholz, Coleen K Cunningham, Petronella Muresan, et al.
The Journal of Infectious Diseases|May 23, 2012
Safety and immunogenicity of 2009 pandemic H1N1 influenza vaccination in perinatally HIV-1-infected children, adolescents, and young adultsPatricia M Flynn, Sharon Nachman, Petronella Muresan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 11, 2015
Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate During PregnancyGeorge K Siberry, Denise L Jacobson, Heidi J Kalkwarf, et al.
The Journal of Infectious Diseases|March 5, 2005
A bovine parainfluenza virus type 3 vaccine is safe and immunogenic in early infancyDavid P Greenberg, Robert E Walker, Min-Shi Lee, et al.
The Journal of Infectious Diseases|March 7, 2018
Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate With Deletion of RNA Synthesis Regulatory Protein M2-2 is Highly Immunogenic in ChildrenElizabeth J McFarland, Ruth A Karron, Petronella Muresan, et al.
Pediatrics|July 25, 2007
Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021Ross E McKinney, John Rodman, Chengcheng Hu, et al.
American Journal of Perinatology|April 17, 2019
SENTINEL1: Two-Season Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving ImmunoprophylaxisEvan J Anderson, John P DeVincenzo, Eric A F Simões, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 20, 2015
Prevalence and Persistence of Varicella Antibodies in Previously Immunized Children and Youth With Perinatal HIV-1 InfectionMurli U Purswani, Brad Karalius, Tzy-Jyun Yao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 9, 2016
Antiretroviral Drug Resistance Among Children and Youth in the United States With Perinatal HIVRussell B Van Dyke, Kunjal Patel, Ron M Kagan, et al.
HIV Medicine|December 6, 2011
Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV-infected childrenT I Miller, W Borkowsky, L A DiMeglio, et al.
Pageof 13

Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
The Journal of Infectious Diseases|March 7, 2018
Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and ChildrenUrsula J Buchholz, Coleen K Cunningham, Petronella Muresan, et al.
The Journal of Infectious Diseases|May 23, 2012
Safety and immunogenicity of 2009 pandemic H1N1 influenza vaccination in perinatally HIV-1-infected children, adolescents, and young adultsPatricia M Flynn, Sharon Nachman, Petronella Muresan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 11, 2015
Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate During PregnancyGeorge K Siberry, Denise L Jacobson, Heidi J Kalkwarf, et al.
The Journal of Infectious Diseases|March 5, 2005
A bovine parainfluenza virus type 3 vaccine is safe and immunogenic in early infancyDavid P Greenberg, Robert E Walker, Min-Shi Lee, et al.
The Journal of Infectious Diseases|March 7, 2018
Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate With Deletion of RNA Synthesis Regulatory Protein M2-2 is Highly Immunogenic in ChildrenElizabeth J McFarland, Ruth A Karron, Petronella Muresan, et al.
Pediatrics|July 25, 2007
Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021Ross E McKinney, John Rodman, Chengcheng Hu, et al.
American Journal of Perinatology|April 17, 2019
SENTINEL1: Two-Season Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving ImmunoprophylaxisEvan J Anderson, John P DeVincenzo, Eric A F Simões, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 20, 2015
Prevalence and Persistence of Varicella Antibodies in Previously Immunized Children and Youth With Perinatal HIV-1 InfectionMurli U Purswani, Brad Karalius, Tzy-Jyun Yao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 9, 2016
Antiretroviral Drug Resistance Among Children and Youth in the United States With Perinatal HIVRussell B Van Dyke, Kunjal Patel, Ron M Kagan, et al.
HIV Medicine|December 6, 2011
Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV-infected childrenT I Miller, W Borkowsky, L A DiMeglio, et al.
Pageof 13